CVE-2009-4413

Public Exploit

Description

The httpClientDiscardBody function in client.c in Polipo 0.9.8, 0.9.12, 1.0.4, and possibly other versions, allows remote attackers to cause a denial of service (crash) via a request with a large Content-Length value, which triggers an integer overflow, a signed-to-unsigned conversion error with a negative value, and a segmentation fault.

Category

5.0
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 12.41% Top 10%
Vendor Advisory debian.org Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/bid/37463 vdb entry
http://www.openwall.com/lists/oss-security/2009/12/12/4 mailing list
http://secunia.com/advisories/38647 third party advisory
http://bugs.debian.org/cgi-bin/bugreport.cgi?bug=560779
http://secunia.com/advisories/37607 third party advisory vendor advisory
http://www.exploit-db.com/exploits/10338 exploit
http://www.debian.org/security/2010/dsa-2002 vendor advisory

Frequently Asked Questions

What is the severity of CVE-2009-4413?
CVE-2009-4413 has been scored as a medium severity vulnerability.
How to fix CVE-2009-4413?
To fix CVE-2009-4413, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2009-4413 being actively exploited in the wild?
It is possible that CVE-2009-4413 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~12% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.